Researchers are hoping to capitalise on a cannabis use side-effect to improve the lives of cancer patients
firm Artelo has been working on a drug which it says imitates the effect of the cannabis plant but only on the body and not the brain, so patients will not get high.The drug, currently referred to as ART27.13 was originally developed by AstraZenecca,
Dr Steven Reich, Artelo’s chief medical officer, said last year that data from their research “supports our confidence in ART27.13’s potential as a supportive care therapy for cancer patients as it may not only increase appetite, but also prevent muscle wasting.”Researchers hope ART23.13 will be able to restore appetite, reverse weight loss and improve the quality of life for cancer patients.
Dr Andy Yates, chief scientific officer at Artelo, said the drug activates the CB1 and CB2 receptors within the body but it is restricted from going to the brain.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Travel could be the best defense against aging, say researchersForget about retinol night creams, researchers from Edith Cowan University (ECU) believe travel could be the best way to defy premature aging.
Read more »
Japanese researchers uncover key mechanism protecting heart cells from ischemiaUnderstanding the mechanisms behind cell death and survival is crucial when it comes to conditions like heart failure, which affects millions of people worldwide.
Read more »
Extortion is a common and harmful experience among Latinx immigrants traveling to the US, researchers findLatinx immigrant adults traveling to the United States are extorted—on average—$804 per research participant throughout the journey, according to a study appearing in Injury Epidemiology.
Read more »
Autoimmune disease researchers find immune cells escape therapy due to 'exhausted' stateIn autoimmune diseases, the immune system mistakenly attacks the body's own structures. A research team from Kiel, Lübeck and Berlin has now succeeded in analyzing certain pathogenic immune cells more precisely using a method they developed.
Read more »
Researchers develop rapid test to detect dopamineDopamine, a neurotransmitter in our brains, not only regulates our emotions but also serves as a biomarker for the screening of certain cancers and other neurological conditions.
Read more »
Researchers make breakthrough in predicting the prognosis of triple-negative breast cancerScientists at Huntsman Cancer Institute at the University of Utah (the U), the National Cancer Institute-designated cancer center for the Mountain West, have made a significant breakthrough in predicting the prognosis of triple-negative breast cancer (TNBC), a particularly aggressive disease.
Read more »